Roivant Sciences Ltd. (ROIV) Earnings
|
Expand Research on ROIV
| Next EPS Date | 8/17/26 | EPS Growth Rate | +12.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +47.2% | Revenue Growth Rate | +6.0% |
| Average % Move 1-Wk after EPS | +8.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/26  |
Q127 | N/A | -$0.29 | N/A | N/A | $2.3M | N/A | N/A | N/A | ||
| 5/20/26 | Q426 | $0.28 | -$0.29 | +$0.57 | $2.52M | $3.76M | N/A |  | | Details | |
| 2/6/26 | Q326 | -$0.38 | -$0.31 | -$0.07 | $1.99M | $5.13M | N/A | | | Details | |
| 11/10/25 | Q226 | -$0.17 | -$0.32 | +$0.15 | $1.57M | $5.6M | N/A | | | Details | |
| 8/11/25 | Q126 | -$0.33 | -$0.25 | -$0.08 | $2.17M | $7.69M | N/A | | | Details | |
| 5/29/25 |
Q425 | N/A | -$0.26 | N/A | N/A | $54.07M | N/A | N/A | N/A | ||
| 2/10/25 | Q325 | $0.23 | -$0.25 | +$0.48 | $9.02M | $8.14M | N/A | | | Details | |
| 11/12/24 | Q225 | -$0.25 | -$0.23 | -$0.02 | $4.48M | $48.63M | N/A | | | Details |
